ACCENTIA BIOPHARMACEUTICALS INC - FORM 10-Q - EX-32.2 - SECTION 906 CERTIFICATION OF CFO - February 11, 2011

Attached files

file filename
10-Q - FORM 10-Q - ACCENTIA BIOPHARMACEUTICALS INCd10q.htm
EX-10.5 - SECURED TERM NOTE BETWEEN ACCENTIA AND VALENS OFFSHORE SPV II - ACCENTIA BIOPHARMACEUTICALS INCdex105.htm
EX-10.2 - TERM LOAN AND SECURITY AGMT - ACCENTIA BIOPHARMACEUTICALS INCdex102.htm
EX-10.4 - SECURED TERM NOTE BETWEEN ACCENTIA AND PSOURCE - ACCENTIA BIOPHARMACEUTICALS INCdex104.htm
EX-10.9 - WARRANT TERMINATION AGMT BETWEEN ACCENITA AND VALENS US - ACCENTIA BIOPHARMACEUTICALS INCdex109.htm
EX-10.3 - SECURED TERM NOTE BETWEEN ACCENTIA AND ERATO - ACCENTIA BIOPHARMACEUTICALS INCdex103.htm
EX-10.7 - WARRANT TERMINATION AGMT BETWEEN ACCENITA AND LAURUS - ACCENTIA BIOPHARMACEUTICALS INCdex107.htm
EX-10.6 - SECURED TERM NOTE BETWEEN ACCENTIA AND VALENS US - ACCENTIA BIOPHARMACEUTICALS INCdex106.htm
EX-10.12 - STOCK PLEDGE AGREEMENT BETWEEN ACCENTIA AND LV ADMINISTRATIVE - ACCENTIA BIOPHARMACEUTICALS INCdex1012.htm
EX-10.24 - FORM OF CONVERTIBLE DEBENTURE (CLASS 9) - ACCENTIA BIOPHARMACEUTICALS INCdex1024.htm
EX-10.16 - FORM OF 8.5% SECURED CONVERTIBLE DEBENTURE - ACCENTIA BIOPHARMACEUTICALS INCdex1016.htm
EX-10.17 - FORM OF COMMON STOCK PURCHASE WARRANT - ACCENTIA BIOPHARMACEUTICALS INCdex1017.htm
EX-10.13 - SECURITY AGMT - ACCENTIA BIOPHARMACEUTICALS INCdex1013.htm
EX-10.22 - FORM OF SECURITY AGMT (CLASS 6) - ACCENTIA BIOPHARMACEUTICALS INCdex1022.htm
EX-10.20 - FORM OF 8.5% SECURED DEBENTURE - ACCENTIA BIOPHARMACEUTICALS INCdex1020.htm
EX-10.23 - FORM OF SUBSIDIARY GUARANTEE (CLASS 6) - ACCENTIA BIOPHARMACEUTICALS INCdex1023.htm
EX-10.11 - STOCK PLEDGE AGREEMENT BETWEEN ACCENTIA AND LV ADMINISTRATIVE - ACCENTIA BIOPHARMACEUTICALS INCdex1011.htm
EX-10.19 - FORM OF SUBSIDIARY AGREEMENT - ACCENTIA BIOPHARMACEUTICALS INCdex1019.htm
EX-10.26 - FORM OF CLASS 13 CONVERTIBLE NOTE - ACCENTIA BIOPHARMACEUTICALS INCdex1026.htm
EX-10.18 - FORM OF PLEDGE AGREEMENT - ACCENTIA BIOPHARMACEUTICALS INCdex1018.htm
EX-10.10 - GUARANTY - ACCENTIA BIOPHARMACEUTICALS INCdex1010.htm
EX-10.15 - GRANT OF SECURITY INTEREST AGMT - ACCENTIA BIOPHARMACEUTICALS INCdex1015.htm
EX-10.14 - GRANT OF SECURITY INTEREST AGMT - ACCENTIA BIOPHARMACEUTICALS INCdex1014.htm
EX-10.21 - FORM OF COMMON STOCK PURCHASE WARRANT - ACCENTIA BIOPHARMACEUTICALS INCdex1021.htm
EX-10.25 - FORM OF COMMON STOCK PURCHASE WARRANT (CLASS 6) - ACCENTIA BIOPHARMACEUTICALS INCdex1025.htm
EX-31.1 - SECTION 302 CERTIFICATION OF CEO - ACCENTIA BIOPHARMACEUTICALS INCdex311.htm
EX-32.1 - SECTION 906 CERTIFICATION OF CEO - ACCENTIA BIOPHARMACEUTICALS INCdex321.htm
EX-31.2 - SECTION 302 CERTIFICATION OF CFO - ACCENTIA BIOPHARMACEUTICALS INCdex312.htm
EX-10.28 - RESIGNATION SETTLEMENT - ACCENTIA BIOPHARMACEUTICALS INCdex1028.htm
EX-10.27 - FORM OF COMMON STOCK PURCHASE WARRANT (CLASS 13) - ACCENTIA BIOPHARMACEUTICALS INCdex1027.htm
EX-10.8 - WARRANT TERMINATION AGMT BETWEEN ACCENITA AND VALENS OFFSHORE SPV I - ACCENTIA BIOPHARMACEUTICALS INCdex108.htm

Exhibit 32.2

CERTIFICATIONS

In connection with the Quarterly Report on Form 10-Q of Accentia Biopharmaceuticals, Inc. (the “Company”) for the three months ended December 31, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Form 10-Q”), I, Garrison J. Hasara, Acting Chief Financial Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Form 10-Q fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: February 11, 2011

 

/s/ Garrison J. Hasara

Garrison J. Hasara, CPA
Acting Chief Financial Officer; Controller

This certification accompanies the Form 10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission, and is not to be incorporated by reference into any filing of Accentia Biopharmaceuticals, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form 10-Q), irrespective of any general incorporation language contained in such filing.

ACCENTIA BIOPHARMACEUTICALS INC Reports

Also read